As of the latest SEC filings, XTL BIOPHARMACEUTICALS LTD (XTLB) is held by 2 institutional funds. The largest fund shareholder is Fidelity Nasdaq Composite Index Fund (FNCMX), holding an estimated $6,791.21 in market value, representing a significant portion of its portfolio.